Envestnet Asset Management Inc Repligen Corp Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 112,251 shares of RGEN stock, worth $18.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
112,251
Previous 108,741 3.23%
Holding current value
$18.6 Million
Previous $13.7 Million 21.87%
% of portfolio
0.01%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$119.79 - $167.35 $420,462 - $587,398
3,510 Added 3.23%
112,251 $16.7 Million
Q2 2024

Aug 08, 2024
BUY
$120.0 - $182.95 $88,920 - $135,565
741 Added 0.69%
108,741 $13.7 Million
Q1 2024

May 13, 2024
BUY
$170.78 - $208.42 $696,611 - $850,145
4,079 Added 3.93%
108,000 $19.9 Million
Q4 2023

Feb 13, 2024
SELL
$114.17 - $185.35 $280,629 - $455,590
-2,458 Reduced 2.31%
103,921 $18.7 Million
Q3 2023

Nov 13, 2023
BUY
$138.78 - $176.51 $4.2 Million - $5.34 Million
30,239 Added 39.71%
106,379 $16.9 Million
Q2 2023

Aug 04, 2023
SELL
$138.42 - $180.31 $42.2 Million - $55 Million
-304,994 Reduced 80.02%
76,140 $10.8 Million
Q1 2023

May 11, 2023
BUY
$154.26 - $198.1 $42.8 Million - $54.9 Million
277,271 Added 266.96%
381,134 $64.2 Million
Q4 2022

Feb 07, 2023
SELL
$162.42 - $220.56 $122,464 - $166,302
-754 Reduced 0.72%
103,863 $17.6 Million
Q3 2022

Nov 10, 2022
SELL
$160.42 - $256.21 $99,941 - $159,618
-623 Reduced 0.59%
104,617 $19.6 Million
Q2 2022

Aug 03, 2022
SELL
$140.68 - $188.02 $1.32 Million - $1.77 Million
-9,388 Reduced 8.19%
105,240 $17.1 Million
Q1 2022

May 04, 2022
BUY
$161.19 - $257.96 $1.31 Million - $2.1 Million
8,122 Added 7.63%
114,628 $21.6 Million
Q4 2021

Feb 04, 2022
BUY
$247.59 - $304.47 $910,883 - $1.12 Million
3,679 Added 3.58%
106,506 $28.2 Million
Q3 2021

Oct 07, 2021
BUY
$194.77 - $324.21 $12.9 Million - $21.5 Million
66,221 Added 180.9%
102,827 $29.7 Million
Q2 2021

Aug 04, 2021
BUY
$165.87 - $220.95 $879,442 - $1.17 Million
5,302 Added 16.94%
36,606 $7.31 Million
Q1 2021

May 04, 2021
BUY
$180.37 - $226.26 $627,867 - $787,611
3,481 Added 12.51%
31,304 $6.09 Million
Q4 2020

Feb 02, 2021
BUY
$148.08 - $206.57 $289,348 - $403,637
1,954 Added 7.55%
27,823 $5.33 Million
Q3 2020

Oct 09, 2020
BUY
$122.51 - $158.27 $398,647 - $515,010
3,254 Added 14.39%
25,869 $3.82 Million
Q2 2020

Jul 08, 2020
BUY
$94.33 - $140.48 $326,853 - $486,763
3,465 Added 18.09%
22,615 $2.8 Million
Q1 2020

Apr 23, 2020
SELL
$84.96 - $109.14 $122,257 - $157,052
-1,439 Reduced 6.99%
19,150 $1.85 Million
Q4 2019

Feb 11, 2020
BUY
$73.84 - $93.08 $16,614 - $20,943
225 Added 1.1%
20,589 $1.9 Million
Q3 2019

Oct 17, 2019
SELL
$76.65 - $95.51 $18,779 - $23,399
-245 Reduced 1.19%
20,364 $1.56 Million
Q2 2019

Aug 02, 2019
SELL
$54.2 - $85.95 $16,531 - $26,214
-305 Reduced 1.46%
20,609 $1.77 Million
Q1 2019

May 10, 2019
BUY
$49.45 - $62.8 $706,887 - $897,726
14,295 Added 215.97%
20,914 $1.24 Million
Q4 2018

Feb 13, 2019
BUY
$48.26 - $68.88 $319,432 - $455,916
6,619 New
6,619 $349,000
Q3 2018

Nov 14, 2018
SELL
$46.8 - $58.97 $375,382 - $472,998
-8,021 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$35.26 - $47.04 $66,676 - $88,952
1,891 Added 30.85%
8,021 $377,000
Q1 2018

May 09, 2018
BUY
$30.92 - $37.27 $30,981 - $37,344
1,002 Added 19.54%
6,130 $222,000
Q4 2017

Feb 20, 2018
SELL
$32.53 - $38.92 $30,903 - $36,974
-950 Reduced 15.63%
5,128 $186,000
Q3 2017

Nov 13, 2017
SELL
$36.98 - $46.06 $45,966 - $57,252
-1,243 Reduced 16.98%
6,078 $233,000
Q2 2017

Aug 14, 2017
BUY
N/A
7,321
7,321 $303,000

Others Institutions Holding RGEN

# of Institutions
485
Shares Held
54.1M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.21B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email